Get started
Work

Supplementary Figure S9 from ATOR-4066, a Bispecific Antibody Targeting CD40 and CEACAM5, Induces Strong Myeloid and T Cell–Dependent Tumor Immunity and Synergizes with PD-1 Blockade

Year: 2025
Type: supplementary-materials
Abstract: Supplementary Figure S9 Individual tumor growth curves of mice treated with 100ug CD40 mAb, 167 ug ATOR-4066 or vehicle.
DOI: 10.1158/2326-6066.30761333
Authors: Hampus Andersson, Ida Uddbäck, Tova Hermodsson, Mona Celander, Amulya Krishna Shetty, Lill Ljung, Anneli Nilsson, Anette Sundstedt, Laura von Schantz, Laura A. Varas, Mattias Levin, Anna Säll, Dietmar Weilguny, Kim Jansson, Sara Fritzell, Karin Hägerbrand, Malin Lindstedt, Peter Ellmark
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: gold
OpenAlex ID: W4416901422
Cites:
Cited by:
Related to: 10